NK cell lysis of HIV-1-infected autologous CD4 primary T cells: requirement for IFN-mediated NK activation by plasmacytoid dendritic cells

J Immunol. 2007 Aug 15;179(4):2097-104. doi: 10.4049/jimmunol.179.4.2097.

Abstract

In vivo, several mechanisms have been postulated to protect HIV-1-infected cells from NK surveillance. In vitro, previous research indicates HIV-1-infected autologous CD4(+) primary T cells are resistant to NK lysis. We hypothesized that NK lysis of HIV-1-infected target cells would be augmented by the presence of accessory cells and/or accessory cell factors. In this study, we show that stimulation of plasmacytoid dendritic cells (PDC) with the TLR9 agonist, CpG ODN 2216, triggered NK lysis of HIV-1-infected autologous CD4(+) primary T cells. PDC-stimulated NK lysis was dependent upon MHC class I (MHC-I) down-regulation on infected cells, and primary HIV-1 isolates that exhibited enhanced MHC-I down-regulation were more susceptible to NK-mediated lysis. PDC-stimulated NK lysis of HIV-1-infected autologous CD4(+) primary T cells was blocked by neutralizing Abs to type 1 IFN and was perforin/granzyme dependent. Overall, our data suggest that HIV-infected cells are not innately resistant to NK lysis, and that exogenous NK stimulation derived from PDC can trigger NK cytotoxicity against HIV-1-infected autologous CD4(+) primary T cells.

Publication types

  • Clinical Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD4-Positive T-Lymphocytes / immunology*
  • CD4-Positive T-Lymphocytes / virology
  • Cells, Cultured
  • Coculture Techniques
  • Dendritic Cells / immunology*
  • Down-Regulation / drug effects
  • Down-Regulation / immunology
  • HIV Infections / immunology*
  • HIV-1 / immunology*
  • Histocompatibility Antigens Class I / immunology
  • Humans
  • Immunity, Innate / drug effects
  • Immunity, Innate / immunology
  • Interferons / immunology*
  • Killer Cells, Natural / immunology*
  • Lymphocyte Activation / drug effects
  • Lymphocyte Activation / immunology*
  • Oligodeoxyribonucleotides / immunology
  • Oligodeoxyribonucleotides / pharmacology
  • Plasma Cells / immunology*
  • Toll-Like Receptor 9 / agonists
  • Toll-Like Receptor 9 / immunology

Substances

  • Histocompatibility Antigens Class I
  • Oligodeoxyribonucleotides
  • TLR9 protein, human
  • Toll-Like Receptor 9
  • Interferons